DCI Center for Prostate & Urologic Cancers
@DukeGUCancer
Followers
1K
Following
2K
Media
258
Statuses
2K
A multidisciplinary center within @DukeCancer focused on patient care and cutting-edge clinical, translational and population research.
Durham, NC
Joined May 2018
We proudly present our 2022 impact report, highlighting valuable contributions to advancing science, research, and health equity and the great work we have achieved with our partners. CTSI Translational Impact: Advancing Equity Read the report ➡️ https://t.co/6qQiQpIJNH
0
12
14
Our own @DukeBiostats @DukeCancer professor Susan Halabi, PhD, was honored by @uabSOPH this week for career achievement. Notably, she was the 1st statistician ever to be named an @ASCO fellow!
Susan Halabi, PhD, professor of biostatistics and bioinformatics (B&B), received the 21st annual Janet L. Norwood Award for Outstanding Achievement by a Woman in Statistical Sciences from @uabSOPH. Halabi is known for her research on #prostatecancer. https://t.co/HYGC8NuQ3Z
0
0
7
1 in 8 men will be diagnosed with #prostatecancer in their lifetime. If caught early, most can be cured. Men over 50, talk to your doc ab #prostate #cancer #screening – a simple blood test could save your life. @DukeCancer
0
3
10
Another great addition to the Duke Oncology Pharmacy team! Welcome Andrea who will be working in our GU Medical Oncology Clinic! @Daniel_J_George @DukeCancer
1
2
35
Incredible work by @DukeFellows very best @hannahdzmd with mentorship by @AarmstrongDuke highlighting the importance of the patient voice in prostate cancer trials! 👏🏻👏🏻👏🏻
Elevating the patient voice in mHSPC trials: see our JCO editorial out today in @JCO_ASCO @DukeGUCancer
0
0
1
Save the date! Registration is open! @UNCurology @UNC_Lineberger @UNCUroOnc @DukeUrology @DukeCancer @DukeGUCancer #bladdercancer #blcsm #walktoendbladdercancer
We're just 117 days away from the Triangle BCAN Walk to End Bladder Cancer! We can't wait to share more details. In the meantime, please make sure to mark your calendar for April 30th!
0
5
6
@DukeGUCancer is hiring a clinical research nurse coordinator. This team is where I got my start in clinical research over 8 years ago and is a great place to learn! @UNCSON @DukeU_NrsngSchl #NurseTwitter
careers.duke.edu
CLINICAL RESEARCH NURSE COORDINATOR
0
2
2
Study by esteemed PCCTC investigator @Daniel_J_George (@DukeGUCancer) and colleagues finds black men with chemotherapy-naïve metastatic prostate cancer initiating novel hormonal therapy may have better outcomes than similarly treated white men https://t.co/mrCiWkcV5w
0
2
10
Register now for the @DukeGUCancer patient education symposium on GU cancers on Friday. Watch for the #kidneycancer session featuring @Daniel_J_George @WilliamKimMD and Dr. Stacey Lisi. https://t.co/KdMVegf1jy
0
1
6
PCCTC investigator @AarmstrongDuke (@DukeGUCancer, @DukeCancer) discusses precision medicine approaches in advanced prostate cancer via @mydocwire
0
1
4
Join us for spring break at Disney! The Duke Urologic Assembly 2022 is on! Both in person and hybrid options are available with a great team of expert speakers for this CME event focused on precision urologic oncology and urology: @DukeGUCancer
https://t.co/4pFMmzTJms
0
1
5
A culture of mentoring fosters creativity & academic productivity. So glad to highlight our group w/ @Daniel_J_George @AarmstrongDuke @MRHarrisonMD & amazing trainees @TheRealJasonZhu @_joycehwang @LandonBrownMD @ChesterKao1 @hannahdzmd @MattLabsMD I was fortunate to work with!
Love hearing about the mentoring here @dukemedicine from @TiansterZhang and others …@LandonBrownMD @MattLabsMD @hannahdzmd @IMResidencyDuke @DukeIMChiefs @TheRealJasonZhu #medicinegrandrounds
0
1
8
Hard to believe @OncHahn is a fellow; during his time at @huntsmancancer & now @MDAndersonNews he has been incredibly prolific. No surprise with mentors like @neerajaiims. Terrific paper w @Daniel_J_George @DukeGUCancer. Great insight & graphics that are sure to appear at #GU22.
Just in @CCR_AACR : Our commentary on work by @StephaneTERRY1 👉⬆️tumor AXL expression associated with ⬇️response to anti-PD-1 therapy. AXL may be a biomarker & Rx target in metastatic #kidneycancer Wonderful job by @OncHahn
https://t.co/pp4VpP7qwX
@OncoAlert @Daniel_J_George
1
8
33
Great PROPHECY team and story summarizing our latest findings: https://t.co/YTRHLvxffD
@DukeGUCancer @DukeCancer @hopkinskimmel @WCMCPathology @ThePCCTC
physicians.dukehealth.org
Liquid biopsies can help identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are unlikely to benefit from anti-androgen therapies, providing clarity for physicians and...
0
12
43
We are back after a break. This time with an episode showcasing resident perspective on managing irAEs. Join hosts @afreenshariffmd @TiansterZhang as they d/w @IMResidencyDuke physicians @nathanhirshy @MFerreiraMD Dr. Harsh Patolia to learn more. 👉
2
1
5
One week to go until #AUA21. Looking forward to debate with @LiMingSu1 on pros and cons of maintaining open RRP experience for urology residency training. Friday September 10th live during plenary session. @DukeUrology @DukeCancer @DukeGUCancer
6
5
59
.@TiansterZhang, of @DukeCancer, discussed key considerations regarding frontline immunotherapy-based combinations in RCC and recent data from pivotal trials examining their use #kcsm
https://t.co/1YMYq4g6jX
0
5
16
Congratulations @TracyLRoseMD @MattMilowsky on your publication! Was great to enroll & treat patients on the trial @DukeGUCancer. More data for neoadjuvant IO-chemo for muscle invasive #bladdercancer. @BladderCancerUS @Daniel_J_George @DrChrisHoimes @AarmstrongDuke 👏👏
Inimitable @TracyLRoseMD @UNCUroOnc @UNCurology @UNC_Lineberger with @MRHarrisonMD & outstanding colleagues @DukeGUCancer publishes in @JCO_ASCO Ph2 neoadjuvant chemo-IO with promising 56% <pT2 rate. Continued progress in #BladderCancer. @BladderCancerUS
0
4
13
Today was a bittersweet day as I held my last clinic session @dukemedicine @DukeCancer. 12 yrs here - these are the halls where I gained my clinical acumen, grew into an oncologist, and developed some research skills. I am so sad and so grateful for every minute of these 12 yrs.
4
1
168
Thrilled to share our latest ARCHES analysis by risk/volume/prior therapy to provide valuable information to men with mHSPC. Great teamwork with @AzadOncology @DukeGUCancer @AstellasUS @pfizer
https://t.co/FG08uTUVpb$
0
4
17